Found 7 matching trials
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS) NA Sphere-9 VT EFS is a prospective, multi-center, non-randomized, unblinded f...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System N/A A prospective, single-arm, multi-center, safety and performance assessment ...
Show More Location
Vilnius University Hospital
Learn More & Join Trial
Treatment of Persistent Atrial Fibrillation With Sphere-9 Catheter and Affera Mapping and Ablation System NA This is a prospective, multicenter, randomized clinical evaluation of the S...
Show More Location
Arrhythmia Institute at Grandview
Learn More & Join Trial
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF) NA Conquer-AF is a prospective, multi-center, interventional, non-randomized c...
Show More Location
University of Alabama at Birmingham (UAB) Hospital
Learn More & Join Trial
Sphere-9 PAF China Study NA The goal of this clinical trial is to find out if the Sphere-9 Catheter and...
Show More Location
Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT) NA Sphere VT is a prospective, multi-center, single-arm, unblinded pivotal cli...
Show More Location
The Ohio State University Wexner Medical Center
Learn More & Join Trial
Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System for Treatment of Atrial and Ventricular Arrhythmias NA A prospective, single-arm, multi-center, safety and performance assessment ...
Show More Learn More & Join Trial